We have located links that may give you full text access.
Prevalence of Antibody against Angiotensin II Type 1 Receptor (AT1R) Among Thai Kidney Transplant Patients.
Transplantation Proceedings 2018 June
BACKGROUND: Non-HLA antibodies specific to angiotensin II type 1 receptor (AT1R-Ab) are associated with antibody-mediated rejection after kidney transplantation. This study aimed to determine the prevalence of AT1R-Ab among pre-transplantation Thai patients and to compare the association of patient demographics with AT1R-Ab levels.
METHODS: This cohort study enrolled nonsensitized kidney transplant patients with negative panel reactive antibodies at King Chulalongkorn Memorial Hospital, Bangkok, Thailand. AT1R-Ab level was measured with the use of an enzyme-linked immunosorbent assay kit in all pre-transplantation serum samples with the use of a cutoff of >17.0 U/mL to distinguish AT1R-Ab+ from AT1R-Ab at risk and AT1R-Ab- groups.
RESULTS: In all, 70 patients were enrolled with a mean age of 45 (range, 17-68) years, of which 52 were male. Six patients (8.6%) were positive for AT1R-Ab (>17.0 U/mL). The mean age in the AT1R-Ab+ group was lower than in the AT1R-Ab at risk and AT1R-Ab- groups (P = .06). Moreover, the AT1R-Ab+ group had significantly more patients ≤30 years of age (P = .01). No differences were found regarding sex, body mass index, transplant characteristics, causes of end-stage renal disease, or kidney biopsy diagnosis.
CONCLUSIONS: This study is the first to report the prevalence of AT1R-Ab among Thai kidney transplant patients. Further studies are suggested for the application of AT1R-Ab detection for routine testing.
METHODS: This cohort study enrolled nonsensitized kidney transplant patients with negative panel reactive antibodies at King Chulalongkorn Memorial Hospital, Bangkok, Thailand. AT1R-Ab level was measured with the use of an enzyme-linked immunosorbent assay kit in all pre-transplantation serum samples with the use of a cutoff of >17.0 U/mL to distinguish AT1R-Ab+ from AT1R-Ab at risk and AT1R-Ab- groups.
RESULTS: In all, 70 patients were enrolled with a mean age of 45 (range, 17-68) years, of which 52 were male. Six patients (8.6%) were positive for AT1R-Ab (>17.0 U/mL). The mean age in the AT1R-Ab+ group was lower than in the AT1R-Ab at risk and AT1R-Ab- groups (P = .06). Moreover, the AT1R-Ab+ group had significantly more patients ≤30 years of age (P = .01). No differences were found regarding sex, body mass index, transplant characteristics, causes of end-stage renal disease, or kidney biopsy diagnosis.
CONCLUSIONS: This study is the first to report the prevalence of AT1R-Ab among Thai kidney transplant patients. Further studies are suggested for the application of AT1R-Ab detection for routine testing.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app